Menopausal Hormone Therapy in Questions and Answers - a Manual for Physicians of Various Specialties

Overview

Journal Prz Menopauzalny

Publisher Termedia

Date 2019 May 23

PMID 31114451

Citations 3

Authors

Tomasz Paszkowski

Malgorzata Binkowska

Romuald Debski

Magdalena Krzyczkowska-Sendrakowska

Violetta Skrzypulec-Plinta

Wojciech Zgliczynski

Affiliations

Soon will be listed here.

Abstract

This manual has been prepared by the Expert Team of the Polish Menopause and Andropause Society for physicians representing various medical specialties who see patients with menopausal symptoms in their daily practice. In order to make the manual as practical as possible, the current state of knowledge on menopausal hormone therapy (MHT) is presented in the form of questions and answers. They address issues which are essential for initiating and managing MHT based on the most up-to-date treatment algorithms and, at the same time, in line with the old maxim "".

Citing Articles

Engineering mesenchymal stem cells for premature ovarian failure: overcoming challenges and innovating therapeutic strategies.

Yuan Z, Zhang Y, He X, Wang X, Wang X, Ren S Theranostics. 2024; 14(17):6487-6515.

PMID: 39479455 PMC: 11519806. DOI: 10.7150/thno.102641.

Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings.

Binkowska M, Jakimiuk A, Paszkowski T, Pawelczyk L, Skrzypulec-Plinta V Prz Menopauzalny. 2022; 21(3):197-199.

PMID: 36254131 PMC: 9551365. DOI: 10.5114/pm.2022.119861.

Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg.

Binkowska M, Jakiel G, Paszkowski T, Skrzypulec-Plinta V, Zgliczynski W Prz Menopauzalny. 2021; 20(3):113-115.

PMID: 34703410 PMC: 8525257. DOI: 10.5114/pm.2021.109887.

References

Palin S, Kumar S, Sturdee D, Barnett A . HRT in women with diabetes--review of the effects on glucose and lipid metabolism. Diabetes Res Clin Pract. 2001; 54(2):67-77. DOI: 10.1016/s0168-8227(01)00277-7. View

Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View

Rossouw J, Prentice R, Manson J, Wu L, Barad D, Barnabei V . Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007; 297(13):1465-77. DOI: 10.1001/jama.297.13.1465. View

Kornacewicz-Jach Z, Czarnecka D, Rynkiewicz A, Kotarski J, Paszkowski T, Pertynski T . [Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system]. Kardiol Pol. 2009; 67(1):72-6. View

Hodis H, Collins P, Mack W, Schierbeck L . The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective. Climacteric. 2012; 15(3):217-28. PMC: 3631510. DOI: 10.3109/13697137.2012.656401. View

Mauvais-Jarvis F, Clegg D, Hevener A . The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 2013; 34(3):309-38. PMC: 3660717. DOI: 10.1210/er.2012-1055. View

. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013; 20(9):888-902. DOI: 10.1097/GME.0b013e3182a122c2. View

Binkowska M, Debski R, Paszkowski T, Sendrakowska M, Zgliczynski W . Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society - state of knowledge as of December 2013. Prz Menopauzalny. 2015; 13(1):1-12. PMC: 4520330. DOI: 10.5114/pm.2014.41078. View

Baber R, Panay N, Fenton A . 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2016; 19(2):109-50. DOI: 10.3109/13697137.2015.1129166. View

10.

Mauvais-Jarvis F, Manson J, Stevenson J, Fonseca V . Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications. Endocr Rev. 2017; 38(3):173-188. PMC: 5460681. DOI: 10.1210/er.2016-1146. View

11.

. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017; 24(7):728-753. DOI: 10.1097/GME.0000000000000921. View

12.

Cobin R, Goodman N . AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE. Endocr Pract. 2017; 23(7):869-880. DOI: 10.4158/EP171828.PS. View

13.

Woods N, Utian W . Quality of life, menopause, and hormone therapy: an update and recommendations for future research. Menopause. 2018; 25(7):713-720. DOI: 10.1097/GME.0000000000001114. View

14.

Rovinski D, Ramos R, Fighera T, Casanova G, Spritzer P . Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Thromb Res. 2018; 168:83-95. DOI: 10.1016/j.thromres.2018.06.014. View